328 related articles for article (PubMed ID: 9721036)
41. Involvement of the endogenous cannabinoid 2 ligand 2-arachidonyl glycerol in allergic inflammation.
Mimura T; Oka S; Koshimoto H; Ueda Y; Watanabe Y; Sugiura T
Int Arch Allergy Immunol; 2012; 159(2):149-56. PubMed ID: 22652530
[TBL] [Abstract][Full Text] [Related]
42. 2-Arachidonoyl-glycerol suppresses interferon-gamma production in phorbol ester/ionomycin-activated mouse splenocytes independent of CB1 or CB2.
Kaplan BL; Ouyang Y; Rockwell CE; Rao GK; Kaminski NE
J Leukoc Biol; 2005 Jun; 77(6):966-74. PubMed ID: 15774549
[TBL] [Abstract][Full Text] [Related]
43. Physiological roles of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand.
Sugiura T
Biofactors; 2009; 35(1):88-97. PubMed ID: 19319851
[TBL] [Abstract][Full Text] [Related]
44. Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice.
Yamaguchi T; Hagiwara Y; Tanaka H; Sugiura T; Waku K; Shoyama Y; Watanabe S; Yamamoto T
Brain Res; 2001 Aug; 909(1-2):121-6. PubMed ID: 11478928
[TBL] [Abstract][Full Text] [Related]
45. A hydrolase enzyme inactivating endogenous ligands for cannabinoid receptors.
Ueda N; Goparaju SK; Katayama K; Kurahashi Y; Suzuki H; Yamamoto S
J Med Invest; 1998 Aug; 45(1-4):27-36. PubMed ID: 9864962
[TBL] [Abstract][Full Text] [Related]
46. Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase.
Rhee MH; Vogel Z; Barg J; Bayewitch M; Levy R; Hanus L; Breuer A; Mechoulam R
J Med Chem; 1997 Sep; 40(20):3228-33. PubMed ID: 9379442
[TBL] [Abstract][Full Text] [Related]
47. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance.
Sugiura T; Kobayashi Y; Oka S; Waku K
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):173-92. PubMed ID: 12052034
[TBL] [Abstract][Full Text] [Related]
48. Endocannabinoids in the central nervous system--an overview.
Fride E
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):221-33. PubMed ID: 12052038
[TBL] [Abstract][Full Text] [Related]
49. Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells.
Bisogno T; Sepe N; Melck D; Maurelli S; De Petrocellis L; Di Marzo V
Biochem J; 1997 Mar; 322 ( Pt 2)(Pt 2):671-7. PubMed ID: 9065792
[TBL] [Abstract][Full Text] [Related]
50. Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine.
González S; Cascio MG; Fernández-Ruiz J; Fezza F; Di Marzo V; Ramos JA
Brain Res; 2002 Nov; 954(1):73-81. PubMed ID: 12393235
[TBL] [Abstract][Full Text] [Related]
51. 2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice.
Gallily R; Breuer A; Mechoulam R
Eur J Pharmacol; 2000 Oct; 406(1):R5-7. PubMed ID: 11011050
[TBL] [Abstract][Full Text] [Related]
52. Endocannabinoids.
Mechoulam R; Fride E; Di Marzo V
Eur J Pharmacol; 1998 Oct; 359(1):1-18. PubMed ID: 9831287
[TBL] [Abstract][Full Text] [Related]
53. Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability.
Lin S; Khanolkar AD; Fan P; Goutopoulos A; Qin C; Papahadjis D; Makriyannis A
J Med Chem; 1998 Dec; 41(27):5353-61. PubMed ID: 9876105
[TBL] [Abstract][Full Text] [Related]
54. Isolation and structure of a brain constituent that binds to the cannabinoid receptor.
Devane WA; Hanus L; Breuer A; Pertwee RG; Stevenson LA; Griffin G; Gibson D; Mandelbaum A; Etinger A; Mechoulam R
Science; 1992 Dec; 258(5090):1946-9. PubMed ID: 1470919
[TBL] [Abstract][Full Text] [Related]
55. Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease.
Di Marzo V; Hill MP; Bisogno T; Crossman AR; Brotchie JM
FASEB J; 2000 Jul; 14(10):1432-8. PubMed ID: 10877836
[TBL] [Abstract][Full Text] [Related]
56. Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures.
Molina-Holgado F; Molina-Holgado E; Guaza C; Rothwell NJ
J Neurosci Res; 2002 Mar; 67(6):829-36. PubMed ID: 11891798
[TBL] [Abstract][Full Text] [Related]
57. Resorcinol-sn-glycerol derivatives: novel 2-arachidonoylglycerol mimetics endowed with high affinity and selectivity for cannabinoid type 1 receptor.
Brizzi A; Cascio MG; Frosini M; Ligresti A; Aiello F; Biotti I; Brizzi V; Pertwee RG; Corelli F; Di Marzo V
J Med Chem; 2011 Dec; 54(24):8278-88. PubMed ID: 22044209
[TBL] [Abstract][Full Text] [Related]
58. The antinociceptive effects of intraplantar injections of 2-arachidonoyl glycerol are mediated by cannabinoid CB2 receptors.
Guindon J; Desroches J; Beaulieu P
Br J Pharmacol; 2007 Mar; 150(6):693-701. PubMed ID: 17179944
[TBL] [Abstract][Full Text] [Related]
59. The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide.
Di Marzo V; Bisogno T; Sugiura T; Melck D; De Petrocellis L
Biochem J; 1998 Apr; 331 ( Pt 1)(Pt 1):15-9. PubMed ID: 9512456
[TBL] [Abstract][Full Text] [Related]
60. Endocannabinoid structure-activity relationships for interaction at the cannabinoid receptors.
Reggio PH
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):143-60. PubMed ID: 12052032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
